Key Financial Inc Acquires New Position in Lam Research Corporation $LRCX

Key Financial Inc bought a new position in shares of Lam Research Corporation (NASDAQ:LRCX) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 460 shares of the semiconductor company’s stock, valued at approximately $45,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Empowered Funds LLC grew its holdings in Lam Research by 10.5% during the 1st quarter. Empowered Funds LLC now owns 187,472 shares of the semiconductor company’s stock valued at $13,629,000 after buying an additional 17,833 shares in the last quarter. Cookson Peirce & Co. Inc. bought a new position in shares of Lam Research in the first quarter valued at approximately $607,000. Glass Wealth Management Co LLC boosted its position in shares of Lam Research by 8.5% in the second quarter. Glass Wealth Management Co LLC now owns 28,870 shares of the semiconductor company’s stock valued at $2,810,000 after acquiring an additional 2,270 shares during the period. First Interstate Bank purchased a new position in Lam Research during the second quarter valued at approximately $230,000. Finally, Gradient Investments LLC increased its holdings in Lam Research by 4.5% during the 2nd quarter. Gradient Investments LLC now owns 244,452 shares of the semiconductor company’s stock worth $23,795,000 after acquiring an additional 10,427 shares during the period. Institutional investors own 84.61% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. KeyCorp raised their price target on shares of Lam Research from $105.00 to $115.00 and gave the company an “overweight” rating in a report on Tuesday, July 15th. Stifel Nicolaus set a $160.00 price objective on Lam Research and gave the company a “buy” rating in a research report on Thursday, October 23rd. The Goldman Sachs Group boosted their target price on Lam Research from $115.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, October 8th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Lam Research in a research report on Wednesday, October 8th. Finally, Needham & Company LLC lifted their price target on shares of Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a research note on Thursday, October 23rd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $148.54.

Insider Transactions at Lam Research

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the sale, the senior vice president owned 251,047 shares in the company, valued at approximately $34,870,428.30. This trade represents a 17.21% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Ava Harter sold 9,010 shares of the business’s stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the transaction, the insider directly owned 56,786 shares in the company, valued at $8,942,091.42. This trade represents a 13.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 62,498 shares of company stock worth $8,875,663. Company insiders own 0.31% of the company’s stock.

Lam Research Stock Performance

Shares of LRCX stock opened at $155.78 on Wednesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $165.22. The stock has a 50 day moving average price of $131.37 and a two-hundred day moving average price of $104.82. The company has a market capitalization of $195.66 billion, a P/E ratio of 34.31, a PEG ratio of 1.68 and a beta of 1.84.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter last year, the business earned $0.86 earnings per share. The business’s revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, September 24th were paid a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. This is a positive change from Lam Research’s previous quarterly dividend of $0.23. The ex-dividend date of this dividend was Wednesday, September 24th. Lam Research’s payout ratio is currently 22.91%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.